Efficacy of Low-Carbohydrate Ketogenic Diet as an Adjuvant Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials > 2021

본문 바로가기

접속자집계

오늘
1,607
전체
2,137,801
TEL:02-3789-7891
사이트 내 전체검색

Home >
2021

Efficacy of Low-Carbohydrate Ketogenic Diet as an Adjuvant Cancer Ther…

작성자 채식영양
작성일 21-01-01 00:00 | 조회 0 | 댓글 0

본문

YF. Yang, PB. Mattamel, T. Joseph, J. Huang, Q. Chen, BO. Akinwunmi, CJP. Zhang, et al. (2021). Efficacy of Low-Carbohydrate Ketogenic Diet as an Adjuvant Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 13(5). https://doi.org/10.3390/nu13051388

PubMed 33918992


[Abstract]
The role of low-carbohydrate ketogenic diet (LCKD) as an adjuvant therapy in antitumor treatment is not well established. This systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to investigate the efficacy of LCKD as an adjuvant therapy in antitumor treatment compared to non-ketogenic diet in terms of lipid profile, body weight, fasting glucose level, insulin, and adverse effects; Methods: In this study, databases such as PubMed, Web of Science, Scopus, CINAHL, and Cochrane trials were searched. Only RCTs that involved cancer participants that were assigned to dietary interventions including a LCKD group and a control group (any non-ketogenic dietary intervention) were selected. Three reviewers independently extracted the data, and the meta-analysis was performed using a fixed effects model or random effects model depending on the I2 value or p-value; Results: A total of six articles met the inclusion/exclusion criteria. In the overall analysis, the post-intervention results = standard mean difference, SMD (95% CI) showed total cholesterol (TC) level = 0.25 (-0.17, 0.67), HDL-cholesterol = -0.07 (-0.50, 0.35), LDL-cholesterol = 0.21 (-0.21, 0.63), triglyceride (TG) = 0.09 (-0.33, 0.51), body weight (BW) = -0.34 (-1.33, 0.65), fasting blood glucose (FBG) = -0.40 (-1.23, 0.42) and insulin = 0.11 (-1.33, 1.55). There were three outcomes showing significant results in those in LCKD group: the tumor marker PSA, p = 0.03, the achievement of ketosis p = 0.010, and the level of satisfaction, p = 0.005; Conclusions: There was inadequate evidence to support the beneficial effects of LCKDs on antitumor therapy. More trials comparing LCKD and non-KD with a larger sample size are necessary to give a more conclusive result.

0
  • 페이스북으로 보내기
  • 트위터로 보내기
  • 구글플러스로 보내기

댓글목록 0

등록된 댓글이 없습니다.

Total 439
2021 목록
번호 제목 글쓴이 날짜 조회 추천
319 텍스트 European Guidelines for Obesity Management in Adults with a … 링크 채식영양 01-01 1 0
318 텍스트 Ketogenic diets and appetite regulation 링크 채식영양 01-01 1 0
317 텍스트 Ketogenic diet alleviates colitis by reduction of colonic gr… 링크 채식영양 01-01 0 0
316 텍스트 Gut flora and metabolism are altered in epilepsy and partial… 링크 채식영양 01-01 1 0
315 텍스트 Clinical efficacy of eucaloric ketogenic nutrition in the CO… 링크 채식영양 01-01 0 0
314 텍스트 Ketogenic Diet for Super-refractory Status Epilepticus: A Ca… 링크 채식영양 01-01 1 0
313 텍스트 The Low-Carbohydrate Diet: Short-Term Metabolic Efficacy Ver… 링크 채식영양 01-01 1 0
312 텍스트 Evaluation of E-Health Applications for Paediatric Patients … 링크 채식영양 01-01 0 0
열람중 텍스트 Efficacy of Low-Carbohydrate Ketogenic Diet as an Adjuvant C… 링크 채식영양 01-01 1 0
310 텍스트 Effects of Low-Carbohydrate versus Mediterranean Diets on We… 링크 채식영양 01-01 1 0
309 텍스트 Ketogenic Diets for Drug-Resistant Epilepsy 링크 채식영양 01-01 0 0
308 텍스트 The Value of Ketone Bodies in the Evaluation of Kidney Funct… 링크 채식영양 01-01 1 0
307 텍스트 Ketogenic diet treatment in diffuse intrinsic pontine glioma… 링크 채식영양 01-01 1 0
306 텍스트 Ketogenic Diet Impairment of Mycobacterium ulcerans Growth a… 링크 채식영양 01-01 1 0
305 텍스트 The influence of low-carbohydrate diets on the metabolic res… 링크 채식영양 01-01 0 0
게시물 검색

한국채식정보. 대표:이광조ㅣsoypaper@hanmail.netㅣ대표전화: 02-3789-7891ㅣ서울시 용산구 갈월동 56-5. 일심빌딩 203호